Does Age Affect Mesothelioma Prognosis?

Age and Treatment Eligibility

The average age at diagnosis for mesothelioma is approximately 72 years, reflecting the long latency period between asbestos exposure and disease development. Younger patients — generally those under 65 to 70 — are often better candidates for aggressive treatment approaches, including curative-intent surgery combined with chemotherapy and radiation.

Older patients may have comorbidities or reduced organ function that limits their ability to tolerate major surgery or aggressive chemotherapy regimens. However, age alone does not determine treatment eligibility. Overall health, cardiac and pulmonary function, and performance status are equally important considerations.

Survival Statistics by Age

Statistical data consistently shows that younger mesothelioma patients have longer median survival times. Patients diagnosed before age 65 tend to have one-year survival rates approximately 15 to 20 percentage points higher than those diagnosed after age 75. Five-year survival rates also show a clear age-related gradient.

These differences are primarily attributed to treatment eligibility rather than age itself. Younger patients are more likely to receive multimodal treatment, which offers the best chance for extended survival.

Maximizing Outcomes at Any Age

Regardless of age, all mesothelioma patients should consult with experienced specialists who can evaluate their specific circumstances and recommend the most appropriate treatment plan. Even patients who are not candidates for surgery may benefit from chemotherapy, immunotherapy, or palliative care approaches that can improve quality of life and extend survival.

Financial resources from legal compensation can help patients of any age access specialized care, clinical trials, and support services that make a meaningful difference in outcomes and quality of life.